This educational program consists of three presentations on homozygous familial hypercholesterolemia.

This course consists of the following:

• HoFH: Why is early diagnosis important? - Prof. Kausik Ray, MD - London, UK
• Optimizing treatment for patients with HoFH - Prof. Erik Stroes, MD, PhD - Amsterdam, The Netherlands
• Novel LDL-c lowering therapies: What is the potential for ANGPTL3 inhibition in HoFH? - Prof. Frederick Raal, MD, PhD - Johannesburg, South Africa

How to obtain your CME certificate

• Watch the three lectures and answer the pre- and post-test questions
• Fill in the evaluation questions
• Download CME Certificate (if your score >70%)

After watching these three videos, the learner should be able to:

• Recall findings from a study on a large worldwide cohort of HoFH patients
• Name the optimal therapy approach for HoFH patients
• Discuss how effects of optimal therapy in HoFH patients can be demonstrated
• Explain the mechanism of action of ANGPTL3 inhibition
• Reproduce the LDL-c-lowering effect of ANGPTL3 inhibition in the ECLIPSE trial

Expert faculty

• Prof. Kausik Ray, MD - London, UK
• Prof. Erik Stroes, MD, PhD - Amsterdam, The Netherlands
• Prof. Frederick Raal, MD, PhD - Johannesburg, South Africa

Target audience

This educational activity is designed for all healthcare professionals with an interest in management of patients with hypercholesterolemia.

CME accreditation

This online course is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1 hour of external CME credit.

Through an agreement between EBAC and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website. Other health care professionals may obtain from the AMA a certificate of having participated in an activity eligible for conversion of credit to AMA PRA Category 1 Credit™.

Funding

Funding for this educational program was provided by an unrestricted educational grant from Ultragenyx

Questions

For questions regarding this activity, please contact us at info@pace-cme.org.